Medpace CEO Sells $10 Million Worth of Stock
August J. Troendle, the CEO and President of Medpace Holdings (MEDP), sold approximately $10 million worth of company stock in a recent transaction. The sale involved 15,978 shares at an average price between $620.00 and $628.68 per share during an open trading window. Despite the large nominal value of the sale, analysts suggest that investors should not be overly concerned as Troendle still holds a significant stake in Medpace—approximately 545,217 shares directly and around 4.7 million indirectly through his control over Medpace Investors, LLC. His remaining holdings represent about $3.27 billion or nearly 19% of the company's market capitalization. Medpace has shown strong financial performance with a trailing twelve-month (TTM) revenue of $2.8 billion and net income of $491.5 million as of August 2026, contributing to its robust stock price growth.
Tickers: $MEDP